OptimizeRx’s CEO Provides 2023 Midyear Strategic Update

May 24, 2023

Streamline Health® Signs Second Enterprise Client

April 25, 2024
Today’s Stock Market in 2-Minutes

April 25, 2024
Cyngn Announces Closing of $5.0 Million Firm Commitment Public Offering of Common Stock

April 25, 2024
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

April 25, 2024